APH1A Protein - Gamma-Secretase Subunit

APH1A Protein - Gamma-Secretase Subunit

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">APH1A Protein — Gamma-Secretase Subunit</th>
</tr>
<tr> [@amyloidbeta2011]
<td class="label">Gene</td> [@notch2011]
<td>[APH1A](/genes/aph1a)</td> [@gammasecretase2012]
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q9Y6X0" target="_blank">Q9Y6X0</a></td>
</tr>
<tr>
<td class="label">PDB Structures</td>
<td><a href="https://www.rcsb.org/structure/5A63" target="_blank">5A63</a>, <a href="https://www.rcsb.org/structure/5BS6" target="_blank">5BS6</a></td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~28 kDa</td>
</tr>
<tr>
<td class="label">Length</td>
<td>257 amino acids</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Endoplasmic reticulum, Golgi apparatus, Plasma membrane</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>APH1 family, Gamma-secretase complex</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>APH-1, APH1-A, Gamma-secretase subunit APH-1A</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

APH1A Protein — Gamma-Secretase Subunit

Introduction

Aph1A Protein Gamma Secretase Subunit is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

...

APH1A Protein - Gamma-Secretase Subunit

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">APH1A Protein — Gamma-Secretase Subunit</th>
</tr>
<tr> [@amyloidbeta2011]
<td class="label">Gene</td> [@notch2011]
<td>[APH1A](/genes/aph1a)</td> [@gammasecretase2012]
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q9Y6X0" target="_blank">Q9Y6X0</a></td>
</tr>
<tr>
<td class="label">PDB Structures</td>
<td><a href="https://www.rcsb.org/structure/5A63" target="_blank">5A63</a>, <a href="https://www.rcsb.org/structure/5BS6" target="_blank">5BS6</a></td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~28 kDa</td>
</tr>
<tr>
<td class="label">Length</td>
<td>257 amino acids</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Endoplasmic reticulum, Golgi apparatus, Plasma membrane</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>APH1 family, Gamma-secretase complex</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>APH-1, APH1-A, Gamma-secretase subunit APH-1A</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

APH1A Protein — Gamma-Secretase Subunit

Introduction

Aph1A Protein Gamma Secretase Subunit is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

APH1A (Anterior Pharynx Defective 1 Homolog A) is a core component of the [gamma-secretase](/entities/gamma-secretase) complex, a unique aspartyl protease that performs regulated intramembrane proteolysis (RIP) [@structure2014]. The protein is encoded by the APH1A gene and is essential for gamma-secretase complex assembly, stability, and function [@aph2003].

The gamma-secretase complex is composed of four essential subunits:

• Presenilin ([PSEN1](/entities/psen1) or PSEN2) — catalytic aspartyl protease
• Nicastrin (NCSTN) — substrate recognition
• APH-1 (APH1A or APH1B) — complex assembly and stability
• PEN-2 (PSENEN) — catalytic activation

APH1A contributes to the proteolytic processing of over 100 type I transmembrane proteins, most notably the [amyloid precursor protein](/entities/app-protein) (APP), which generates [amyloid-beta](/proteins/amyloid-beta) peptides central to Alzheimer's Disease pathogenesis [@gammasecretase2015].

Structure

Membrane Topology

APH1A is a polytopic membrane protein with seven transmembrane domains [@aph2003]:

N-terminus (luminal)
|
TM1 - TM2 - TM3 - TM4 - TM5 - TM6 - TM7
|
C-terminus (cytoplasmic)

Key Structural Features

| Feature | Description |
|---------|-------------|
| Transmembrane domains | 7 helical segments |
| N-terminal domain | Lumen-facing, interacts with nicastrin |
| C-terminal domain | Cytoplasmic, involved in complex assembly |
| GxxxG motifs | Dimerization interfaces |
| Glycosylation | N-linked glycosylation in luminal domain |

Gamma-Secretase Complex Structure

The gamma-secretase complex has a characteristic "horseshoe" or "C-shaped" structure [@architecture2015]:

• Presenelin forms the catalytic core
• Nicastrin serves as the "lid" for substrate recognition
• APH-1 forms a scaffold stabilizing the complex
• PEN-2 activates the catalytic site

Normal Function

Gamma-Secretase Complex Assembly

APH1A plays essential roles in complex biogenesis [@aph2003]:

Complex formation — APH1A assembles with nicastrin first

Presenilin recruitment — brings in presenilin precursor

PEN-2 incorporation — enables activation

Complex stabilization — maintains quaternary structure

Substrate Processing

The gamma-secretase complex performs RIP on numerous substrates [@gammasecretase2015]:

Major Substrates

| Substrate | Function | Consequence of Cleavage |
|-----------|----------|------------------------|
| APP | Amyloid precursor | Aβ generation (AD) |
| Notch | Developmental signaling | NICD release |
| E-cadherin | Cell adhesion | Signaling |
| ErbB4 | Growth factor | Signaling |
| [LRP1](/proteins/lrp1) | Lipoprotein receptor | Aβ clearance |
| IL-1R1 | Inflammation | Signaling |

Cleavage Mechanism

Substrate binds to nicastrin extracellular domain

Substrate transmembrane domain docks to presenilin

Intramembrane proteolysis occurs (ε-cleavage, then γ-cleavage)

Intracellular domain released for signaling

Tissue Distribution

APH1A is widely expressed:

• Brain (highest in [cortex](/brain-regions/cortex), hippocampus)
• Heart, lung, liver, kidney
• Peripheral tissues

In the brain, gamma-secretase is expressed in [neurons](/entities/neurons) and glia.

Role in Disease

Alzheimer's Disease

APH1A is directly implicated in AD through amyloid-beta generation [@gammasecretase2015][@amyloidbeta2011]:

APP Processing

• Gamma-secretase cleaves C99 to release Aβ peptides
• Aβ40 (80-90%) and Aβ42 (5-10%) are major products
• Aβ42 is more aggregation-prone and neurotoxic
• Aβ43 also implicated in early-onset AD

Genetic Factors

• APH1A polymorphisms associated with AD risk
• eQTLs affect expression and AD susceptibility
• May modify age of onset

Therapeutic Implications

• Gamma-secretase is a major drug target
• Inhibitors — complete blockade problematic (Notch toxicity)
• Modulators — shift cleavage toward shorter Aβ
• APH1A-targeted — more selective approaches in development

Cancer

Gamma-secretase processes Notch receptors, which are oncogenic when dysregulated [@notch2011]:

• Breast cancer
• T-cell acute lymphoblastic leukemia
• Various solid tumors
• APH1A as potential therapeutic target

Other Diseases

• Acne inversa — gamma-secretase mutations (via Notch)
• Hutchinson-Gilford progeria — lamin A processing

Therapeutic Targeting

Gamma-Secretase Modulators (GSMs)

Rather than inhibiting all cleavage, GSMs shift the processing pattern [@gammasecretase2012]:

| Type | Effect | Status |
|------|--------|--------|
| NSAID-derived | Reduce Aβ42 | Clinical trials |
| Natural compounds | Various | Research |
| APH1A-selective | Modified specificity | Preclinical |

Challenges

Notch toxicity — broad inhibition causes GI, immune effects

Substrate selectivity — difficult to achieve

Mechanism — complex allosteric modulation

See Also

• [Proteins Index](/proteins)
• [Genes Index](/genes)
• [APH1A Gene](/genes/aph1a)
• [Presenilin-1 Protein](/proteins/psen1-protein)
• [Gamma-Secretase Complex](/gamma-secretase-complex)
• [Amyloid-Beta Protein](/proteins/amyloid-beta)
• [Alzheimer's Disease](/diseases/alzheimers-disease)

External Links

• UniProt: [https://www.uniprot.org/uniprot/Q9Y6X0](https://www.uniprot.org/uniprot/Q9Y6X0)
• PDB: [https://www.rcsb.org/structure/5A63](https://www.rcsb.org/structure/5A63)
• AlphaFold: [https://alphafold.ebi.ac.uk/entry/Q9Y6X0](https://alphafold.ebi.ac.uk/entry/Q9Y6X0)

Background

The study of Aph1A Protein Gamma Secretase Subunit has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[Unknown, Structure of the gamma-secretase complex. Nature, 2014 (2014)](https://doi.org/10.1038/nature13550)

[Unknown, APH1 proteins in gamma-secretase assembly. Journal of Biological Chemistry, 2003 (2003)](https://doi.org/10.1074/jbc.M302627200)

[Unknown, Gamma-secretase: from physiology to pathology. Nature Reviews Neuroscience, 2015 (2015)](https://doi.org/10.1038/nrn3970)

[Unknown, Architecture of the gamma-secretase complex. EMBO Reports, 2015 (2015)](https://doi.org/10.15252/embr.201439411)

[Unknown, Amyloid-beta generation and Alzheimer's disease. Biochemical Society Transactions, 2011 (2011)](https://doi.org/10.1042/BST0391067)

[Unknown, Notch signaling in cancer. Nature Reviews Cancer, 2011 (2011)](https://doi.org/10.1038/nrc3023)

[Unknown, Gamma-secretase modulators for Alzheimer's disease. Nature Reviews Drug Discovery, 2012 (2012)](https://doi.org/10.1038/nrd3576)